Wednesday April 17, 2002
10.00–11.45
SSG Board meeting, Room: Atlas
11.00–12.00
Registration
12.00–13.50
Separate surgery working group meeting
Room: Atlas
Chairman: G. Follerås, Oslo
13.00–14.00
Lunch
14.00
Introduction, Room: Auditoriet
T.A. Alvegård, Lund, H. Bauer, Stockholm
14.15–16.00
Gastrointestinal Stroma Cells Tumor (GIST)
Chairmen: K. Sundby Hall, Oslo, J. Åhlén, Stockholm
14.15
1. Gastrointestinal Stromal (Pacemaker Cell) Tumor – An update on morphology, prognosis, KIT mutations, cytogenetics, and its relationship to NF1
J. Meis-Kindblom, L.G. Kindblom, Gothenburg
14.45
2. Surgical aspects of gastrointestinal stromal tumors
B. Nilsson, P. Bümming, L.G. Kindblom, S. Jansson, H. Ahlman, Gothenburg
15.15
3. Systemic treatment of GIST from overtly metastatic disease to adjuvant therapy
H. Joensuu, Helsinki
16.00
Coffee
16.30–17.30
Positron Emissions Tomography (PET)
Chairmen: I. Taksdal, Oslo, K. Jonsson, Lund
16.30
4. Coincidence PET
M. Winderen, I.Taksdal, Oslo
16.50
5. Therapy monitoring in high grade bone sarcomas with FDG-PET during neoadjuvant treatment – preliminary results and study suggestion
E. Brun, J. Engellau, T. Ohlsson, A. Sandell, T. Wiebe, H. Domanski, Lund
17.10
6. Dedicated PET
P. Lindholm for the Sarcoma Groups of University Hospitals in Turku and Helsinki and Turku PET Centre, Finland
17.30–18.00
Free paper
17.30
7. Fibromatosis
H. Einarsdottir, Stockholm
19.30
Dinner at Scandic Hotel Slussen
Thursday April 18, 2002
07.30–08.30
Breakfast
08.30–13.00
Bone Sarcomas
Chairmen: H. Bauer, Stockholm, S. Smeland, Oslo
08.30
8. Copy number changes, fusions, mutations and aberrant expression of genes in osteosarcoma
S. Knuutila, Helsinki
09.00
9. Radiological diagnosis of Ewing´s family tumors
K. Jonsson, Lund, I. Taksdal, M. Winderen, Oslo
09.30
10. Surgical aspects of pelvic tumors
W. Winkelmann, Münster
10.00
Discussion
10.15
11. Autobiological reconstructions with preserved joint function after surgical treatment of bone sarcoma in children
Ö. Berlin, P. Bergh, B. Gunterberg, J. Lundberg, H. Mark, Gothenburg
10.45
12. ISG/SSG´s prognostic factors study in osteosarcoma
S. Smeland, Oslo, R. Perfekt, Lund, S. Ferrari, Bologna et al.
11.15
Coffee
11.45
13. Clinical results of ISG/SSG I, II and SSG XIV
S. Smeland, Oslo for the Scandinavian Sarcoma Group
12.10
14. Preliminary results of ISG/SSG III and IV (Ewing´s family tumors)
T. Wiebe, T.A. Alvegård, Lund, S. Smeland, Oslo
12.30
15. Very high risk Ewing tumors – overview.
O. Monge, Bergen
12.40
16. Quality of life investigation and long-term morbidity in bone sarcoma patients – present status
L.H. Aksnes, Oslo, H. Bauer, Stockholm, R. Huuhtanen, Helsinki, K. Sundby Hall, Oslo
13.00–14.00
Lunch
14.00–17.00
Soft Tissue Sarcoma (STS)
Chairmen: A. Rydholm, Lund, P. Lindholm, Turku
14.00
17. Radiation therapy for soft tissue sarcoma – “State of the art”
B. O´Sullivan, D. Jaffray, Toronto
14.30
Discussion
14.45
18. High-throughput tumor profiling using DNA microarrays
O. Myklebost, Oslo
15.15
19. Preliminary results of SSG XIII (adjuvant chemotherapy in high-risk patients)
T.A. Alvegård, Lund
15.30
Coffee
16.00
20. Thermochemotherapy in high risk sarcoma patients
O. Monge, B.C. Schem, T. Frøystein, C. Trovik, H.E. Oulie, J. Eide, A. Horn, O. Mella, Bergen
16.15
21. Proposal: Adjuvant chemotherapy for Isolated Limb Perfusion (ILP) treated patients?
K. Sundby Hall, Oslo, T.A. Alvegård, Lund
16.30
22. Proposal: Treatment of adult patients with rhabdomyosarcoma
K. Sundby Hall, S. Smeland, J.P. Poulsen, Oslo
16.45
23. Myositis ossificans: radiological findings in 7 cases
I. Taksdal, B. Bjerkehagen, Oslo
17.00–17.45
Reception, room: Panorama
18.45
Walking from the Scandic Hotel Slussen to the Stockholm Opera
19.30
Start of the Opera Ballet performance
22.00
Buffet at the Opera restaurant
Friday April 19, 2002
08.30–09.30
Breakfast
09.30
24. Preliminary data from the SSG skeletal metastasis data base
J. Keller, Aarhus, R. Wedin, Stockholm
10.00–11.30
Presentation of final version: SSG recommendations for the diagnosis and treatment of intraabdominal and retroperitoneal sarcomas
B. Bjerkehagen, I. Taksdal, S. Stoldt, Ø. Bruland, K. Sundby Hall, Oslo J. Åhlén, Stockholm, P. Helgerud, G. Kristensen, Oslo, C. Blomqvist, Uppsala, A. Bergenfelz, Lund, K. Engström, Gothenburg, J.O. Fernberg, Stockholm, R. Huuhtanen, Helsinki, O. Monge, Bergen, L. Blomqvist, Stockholm, L. Lundgren-Eriksson, Umeå, B. Nordström, Gothenburg, M. Eriksson, T.A. Alvegård, Lund
Chairmen: T.A. Alvegård, Lund, H. Bauer, Stockholm
11.30–12.00
Coffee
12.00–13.00
SSG matters
T.A. Alvegård, Lund, H. Bauer, Stockholm, K. Sundby Hall, Oslo
13.00–14.00 Lunch